Skip to main content
news
A man passes a logo of Japan's Olympus Corp outside the company showroom in Tokyo December 21, 2012. REUTERS/Yuriko Nakao

TMI Associates has advised Japanese optic technology company Olympus on the $3.1 billion sale of its industrial microscope subsidiary EVIDENT to U.S. private equity company Bain Capital, which was represented by Nishimura & Asahi.

This is Olympus’ biggest divestment yet, Reuters reported. The sale of the unit, which also makes industrial endoscopes and x-ray analysers, comes as Olympus speeds up the overhaul of its business portfolio to focus solely on medical technology, Reuters added.

The TMI team was led by partner Takushi Saito, while the Nishimura team was led by partners Yuki Oi, Kohei Ishida, Takeshi Nemoto, and Junko Wakabayashi.

Also advising Olympus on different legs of the deal were India’s Khaitan & Co and Canada’s Torys. The Khaitan team was led by partner Zakir Merchant with assistance from partners Anshul Prakash and Nishad Nadkarni, while the Torys team was led by partners Don Bell, Guillaume Lavoie, Michael Fortier, Molly Reynolds, and Omar Wakil.

TO CONTACT EDITORIAL TEAM, PLEASE EMAIL ALBEDITOR@THOMSONREUTERS.COM

Related Articles

Khaitan, SAM, Sidley advise on Torrent Power’s $413 mln QIP

by Nimitt Dixit |

Indian law firm Khaitan & Co has advised Torrent Power on its equity offering of $413 million through a qualified institutional placement of shares. Shardul Amarchand Mangaldas & Co and Sidley Austin advised the bookrunning lead managers on the deal.

IndusLaw guides Zepto’s $350 mln funding round

by Nimitt Dixit |

IndusLaw has guided Indian quick commerce company Zepto on its latest $350 million funding round led by Motilal Oswal's Private Wealth division.

9 firms advise on milestone $8.2 bln cross-border insurance deal

by Sarah Wong |

Global law firms Debevoise & Plimpton, Kirkland & Ellis and Herbert Smith Freehills are acting for Bermuda-based insurer Resolution Life on its $8.2 billion sale to Japan’s Nippon Life Insurance, the largest overseas acquisition by a Japanese insurer to date.